FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine and is a method for predicting the risk of cardiovascular disease in a female, which includes: determining the level of pro-neurotensin 1-117 in the blood serum, blood plasma or whole blood, correlating the level of pro-neurotensin 1-117 with the risk of cardiovascular pathology, where an elevated level is prognostic for a high risk and where said cardiovascular pathology is a myocardial infarction, stroke, acute heart failure and death associated with myocardial infarction, stroke or acute heart failure, and where the level of pro-neurotensin 1-117 is determined on an empty stomach.
EFFECT: invention provides effective prediction of the risk of developing cardiovascular disease in a female.
10 cl, 2 dwg, 3 ex, 21 tbl
